Lasa Supergenerics Limited (LASA.BO)
INR 29.0
(-0.82%)
INR 29.0
(-0.82%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -458 Million INR | 53.07% |
| 2022 | -181.28 Million INR | -880.47% |
| 2021 | 23.22 Million INR | -92.67% |
| 2020 | 317 Million INR | 103.54% |
| 2019 | 155.74 Million INR | 295.63% |
| 2018 | -79.61 Million INR | -134.45% |
| 2017 | 231.08 Million INR | -39.35% |
| 2016 | 381 Million INR | 0.0% |
| 2015 | - INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -9.96 Million INR | 85.0% |
| 2023 Q1 | 14 Million INR | 725.04% |
| 2023 FY | -85.06 Million INR | 53.07% |
| 2023 Q2 | -16.38 Million INR | -217.01% |
| 2023 Q3 | -16.26 Million INR | 0.7% |
| 2023 Q4 | -66.42 Million INR | -308.29% |
| 2022 Q3 | -55.53 Million INR | -61.65% |
| 2022 Q1 | -111.93 Million INR | -250.26% |
| 2022 FY | -181.28 Million INR | -880.47% |
| 2022 Q4 | 1.69 Million INR | 103.06% |
| 2022 Q2 | -34.35 Million INR | 69.31% |
| 2021 Q1 | 11.56 Million INR | -77.53% |
| 2021 FY | 23.22 Million INR | -92.67% |
| 2021 Q4 | 74.49 Million INR | 256.07% |
| 2021 Q3 | -47.73 Million INR | -117.02% |
| 2021 Q2 | -21.99 Million INR | -290.21% |
| 2020 Q2 | 91.92 Million INR | 9.0% |
| 2020 FY | 317 Million INR | 103.54% |
| 2020 Q4 | 51.45 Million INR | -40.61% |
| 2020 Q1 | 84.33 Million INR | 28.94% |
| 2020 Q3 | 86.63 Million INR | -5.75% |
| 2019 FY | 155.74 Million INR | 295.63% |
| 2019 Q3 | 40.11 Million INR | 24.33% |
| 2019 Q2 | 32.26 Million INR | 274.85% |
| 2019 Q1 | 8.6 Million INR | 154.41% |
| 2019 Q4 | 65.4 Million INR | 63.04% |
| 2018 Q4 | -15.82 Million INR | 65.74% |
| 2018 Q3 | -46.17 Million INR | -1171.77% |
| 2018 Q2 | -3.63 Million INR | -180.05% |
| 2018 Q1 | 4.53 Million INR | 108.74% |
| 2018 FY | -79.61 Million INR | -134.45% |
| 2017 FY | 231.08 Million INR | -39.35% |
| 2017 Q2 | 82.97 Million INR | -41.53% |
| 2017 Q4 | -51.88 Million INR | -155.92% |
| 2017 Q3 | 92.76 Million INR | 11.81% |
| 2017 Q1 | 141.9 Million INR | 0.0% |
| 2016 Q1 | 94.02 Million INR | 0.0% |
| 2016 FY | 381 Million INR | 0.0% |
| 2015 FY | - INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Ajanta Pharma Limited | 19.67 Billion INR | 102.328% |
| Amrutanjan Health Care Limited | 457.54 Million INR | 200.101% |
| Sigachi Industries Limited | 1.47 Billion INR | 131.074% |
| Bal Pharma Limited | 233.9 Million INR | 295.805% |
| Ind-Swift Laboratories Limited | 4.42 Billion INR | 110.361% |
| Medico Remedies Limited | 100.3 Million INR | 556.635% |
| Venus Remedies Limited | 534.65 Million INR | 185.664% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 88.87% |
| Alpa Laboratories Limited | 184.49 Million INR | 348.245% |
| Nectar Lifesciences Limited | 923.8 Million INR | 149.578% |
| Shilpa Medicare Limited | 1.36 Billion INR | 133.522% |
| Aarti Drugs Limited | 7.14 Billion INR | 106.407% |
| Lupin Limited | 28.04 Billion INR | 101.633% |
| Aurobindo Pharma Limited | 42.2 Billion INR | 101.085% |
| Zydus Lifesciences Limited | 43.1 Billion INR | 101.062% |
| Windlas Biotech Limited | 1.29 Billion INR | 135.261% |
| Suven Life Sciences Limited | -1.22 Billion INR | 62.637% |
| Eris Lifesciences Limited | 5.18 Billion INR | 108.839% |
| Valiant Laboratories Limited | - INR | Infinity% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | 103.207% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 88.113% |
| Ipca Laboratories Limited | 7.98 Billion INR | 105.739% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | 137.206% |
| Achyut Healthcare Limited | 4.43 Million INR | 10420.077% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 100.439% |
| Bajaj HealthCare Limited | - INR | Infinity% |
| RPG Life Sciences Limited | 2.29 Billion INR | 119.98% |
| Mankind Pharma Limited | 21.51 Billion INR | 102.128% |
| Laurus Labs Limited | 3.94 Billion INR | 111.599% |
| Piramal Pharma Limited | 4.55 Billion INR | 110.051% |
| Syncom Formulations (India) Limited | 249.25 Million INR | 283.753% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 101.808% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 107.954% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 107.044% |
| Unichem Laboratories Limited | - INR | Infinity% |
| Sequent Scientific Limited | - INR | Infinity% |
| Novartis India Limited | 626.5 Million INR | 173.105% |
| Wanbury Limited | 569.71 Million INR | 180.392% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 109.94% |
| Wockhardt Limited | -670 Million INR | 31.641% |
| Themis Medicare Limited | 392.58 Million INR | 216.663% |
| Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | 190.135% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 108.826% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 105.101% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 100.676% |
| Divi's Laboratories Limited | 33.08 Billion INR | 101.385% |
| NATCO Pharma Limited | 25.96 Billion INR | 101.764% |
| Gufic Biosciences Limited | 1.32 Billion INR | 134.439% |
| IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | 128.683% |
| Ind-Swift Limited | 1.22 Billion INR | 137.359% |
| Procter & Gamble Health Limited | 2.78 Billion INR | 116.44% |
| FDC Limited | 2.98 Billion INR | 115.337% |
| Krebs Biochemicals & Industries Limited | -151.95 Million INR | -201.404% |
| Granules India Limited | 6.81 Billion INR | 106.719% |
| Medicamen Biotech Limited | - INR | Infinity% |
| Alkem Laboratories Limited | 19.46 Billion INR | 102.353% |
| AstraZeneca Pharma India Limited | 1.71 Billion INR | 126.667% |
| Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | 5150.393% |
| Brooks Laboratories Limited | 14.44 Million INR | 3271.78% |
| Megasoft Limited | -121.1 Million INR | -278.191% |
| ZIM Laboratories Limited | 253.82 Million INR | 280.438% |
| Strides Pharma Science Limited | 5.22 Billion INR | 108.764% |
| Neuland Laboratories Limited | 5.31 Billion INR | 108.612% |
| Morepen Laboratories Limited | 4.17 Billion INR | 110.973% |
| Hikal Limited | 32.11 Million INR | 1526.363% |
| Indoco Remedies Limited | 1.29 Billion INR | 135.434% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | 114.642% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | 320.142% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | 1768.02% |
| Hester Biosciences Limited | 364.81 Million INR | 225.546% |